Management of post-chemotherapy extra-retroperitoneal residual masses

摘要

Introduction Testicular cancer is the most common cancer in men age 20–35 years and accounts for approximately 1% of all male malignancies. While the retroperitoneum is often the first and only site of metastatic disease, approximately 40% of patients presenting with metastatic disease will have disease involving extra-retroperitoneal sites.